We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc

Delisted

ALPN was delisted on the 17th of May, 2024.

41 hedge funds and large institutions have $183M invested in Alpine Immune Sciences Inc in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+41
Holders Change %
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
41
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

ALPN Hedge Fund Activity: Q2 2015 in Review

41 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q2 2015, worth a combined $183M.

Buyers outnumbered sellers: 41 funds opened new ALPN positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $55.6M.

  • 41 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $183M of Alpine Immune Sciences Inc stock for Q2 2015.
  • 41 funds opened new Alpine Immune Sciences Inc positions in Q2 2015 and 0 closed out, a net change of +41 holders.
  • The largest Alpine Immune Sciences Inc buyer in Q2 2015 was Deerfield Management, an estimated $55.6M added.

Based on aggregated 13F filings for Q2 2015.